Clinical Trials Directory

Trials / Completed

CompletedNCT04845984

Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Four Hospital of the Alpine Region

Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Five Hospital of the Alpine Region

Status
Completed
Phase
Study type
Observational
Enrollment
3,500 (actual)
Sponsor
Centre Hospitalier Annecy Genevois · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The PACAAP study aims to report the seroprevalence of SARS-CoV-2 IgG antibodies among HCWs testing during the massive campaign screening set up in France by French ministry of Health and national authorities in four hospital of the Alpine region.

Detailed description

In France during the first wave of the pandemic, 30,230 symptomatic healthcare workers had been reported positive. Yet, the prevalence of the infection in French healthcare workers remains unknown as it mostly reflect symptomatic infections. Also, the prevalence of infection was reported being higher in male healthcare workers, and in those having patients' facing roles. However, the impact of the level of exposure to SARS-CoV-2, the use of personal protective equipment and hospital organization to prevent infection and spread remains unclear. Our study aims to report the seroprevalence of SARS-CoV-2 infection among French healthcare workers after the first wave of the pandemic. It also aims to explore the impact of the type of occupations and the level of exposure to the viruses on the seroprevalence of infection.

Conditions

Timeline

Start date
2020-09-01
Primary completion
2021-01-15
Completion
2021-01-15
First posted
2021-04-15
Last updated
2021-04-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04845984. Inclusion in this directory is not an endorsement.